Recursos de colección

ORBi Open Repository and Bibliography (288.589 recursos)

In may 2007, the ULg's Administrative Board (joined in June 2007 by the FUSAGx) decided to create an institutional repository and defined a strong institutional self-archiving policy to increase the visibility, accessibility and impact of the University's publications (Board's decision). This decision led to the official launch, in November 2008, of the ORBi platform including both the Academic Bibliography and the Institutional Repository of the Wallonia-Europe University Academy.

Human health sciences => Hematology

Mostrando recursos 1 - 20 de 1.072

  1. Despite inhibitory effects on normal hematopoiesis in vitro, Imatinib and Nilotinib do not prevent engraftment of human CD34+ HSCs in immunodeficient NSG mice

    Belle, Ludovic; Baron, Frédéric; Bruck, France; Hannon, Muriel; SERVAIS, Sophie; Beguin, Yves; BRIQUET, Alexandra
    Peer reviewed

  2. Imatinib and Nilotinib do not prevent adhesion and migration of human CD34+ in vitro and in immunodeficient mice

    Belle, Ludovic; Bruck, France; FOGUENNE, Jacques; Gothot, André; Beguin, Yves; Baron, Frédéric; BRIQUET, Alexandra
    Peer reviewed

  3. Prevention of murine sclerodermatous chronic graft-versus-host disease by Rapamycin

    Belle, Ludovic; BINSFELD, Marilène; DUBOIS, Sophie; Hannon, Muriel; Caers, Jo; BRIQUET, Alexandra; MENTEN, Catherine; BEGUIN, Yves; Humblet-Baron, S; Baron, Frédéric
    Peer reviewed

  4. Combination Of Regulatory T Cells and Rapamycin As Treatment For Experimental Chronic Graft-Versus-Host Disease

    Belle, Ludovic; Ehx, Grégory; SOMJA, Joan; BINSFELD, Marilène; Hannon, Muriel; Caers, Jo; Fransolet, Gilles; Beguin, Yves; Humblet-Baron, S; Baron, Frédéric
    Peer reviewed

  5. Host Interleukin 6 and Indoleamine 2,3 Dioxygenase Regulate Inflammation in the Brain during Graft Versus Host Disease

    Belle, Ludovic; Koester, E; Hansen, E; Lawlor, M; Hillard, C; Drobyski, WR
    Peer reviewed

  6. Rapamycin prevents experimental sclerodermatous chronic graft-versus-host disease in mice

    Belle, Ludovic; BINSFELD, Marilène; Dubois, Sophie; Hannon, Muriel; CAERS, Jo; BRIQUET, Alexandra; MENTEN, Catherine; Beguin, Yves; Humbelt-Baron, Stéphanie; BARON, Frédéric
    Peer reviewed

  7. Blockade of Interleukin 27 Signaling Attenuates Graft Versus Host Disease By Augmenting CD4+ and CD8+ Regulatory T Cell Reconstitution

    Belle, Ludovic; Agle, K; Zhou, V; Yuan, V; Sun, J; Ghilardi, N; van Snick, J; Drobyski, WR
    Peer reviewed

  8. Host Interleukin 6 and Indoleamine 2,3 Dioxygenase Regulate Inflammation in the Brain during Graft Versus Host Disease

    Belle, Ludovic; Koester, Erin; Hansen, Emily; Lawlor, Michael; Hillard, Cecilia; Drobyski, William
    Peer reviewed

  9. L'anémie chez les patients BPCO sévères, une comorbidité dont la prévalence est bien plus fréquente que ce que l'on croit

    Pirotte, M; GUIOT, Julien; BEGUIN, Yves; LOUIS, Renaud
    Peer reviewed

  10. Reduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

    Gauthier, J; Castagna, L; Garnier, F; Guillaume, T; Socié, G; Maury, S; Maillard, N; Tabrizi, R; Marchand, T; Malfuson, J-V; Gac, A-C; Gyan, E; Mercier, M; BEGUIN, Yves; Delage, J; Turlure, P; Marcais, A; Nguyen, S; Dulery, R; Bay, J-O; Huynh, A; Daguindau, E; Cornillon, J; Regny, C; Michallet, M; Peffault de la Tour, R; Yakoub-Agha, I; Blaise, D
    Peer reviewed

  11. Ets genes: new roles, future directions

    Spyropoulos, Demetri D.; Pharr, Pamela N.; Lavenburg, Kim R.; Jackers, Pascale; Papas, Takis S.; Ogawa, Makio; Watson, Dennis K.
    Peer reviewed

  12. Contribution of the proteomics platform to molecular imaging targets?

    Bertrand, Virginie; Massart, Anne-Cécile; Jackers, Pascale; De Pauw, Edwin
    Our role in the “KeyMarker” project is to characterize specific biomarkers involved into different pathologies. These pathologies are linked to the concerned associates of the project. We proposed to use original proteomic methods to identify these biomarkers. The first part of our work is to characterize these predictive markers into the plasma of women treated for breast cancer chemotherapy. These potential biomarkers are present into the plasma as low abundant proteins. They are entirely masked by highly abundant proteins and significantly complicate the discovery process by limiting the detection of low abundance proteins. We proposed to use protein depletion to...

  13. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.

    DETRY, Olivier; VANDERMEULEN, Morgan; DELBOUILLE, Marie-Hélène; SOMJA, Joan; BLETARD, Noëlla; Briquet, Alexandra; LECHANTEUR, Chantal; GIET, Olivier; BAUDOUX, Etienne; Hannon, Muriel; Baron, Frédéric; Beguin, Yves
    Peer reviewed

  14. Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation

    SERVAIS, Sophie; GREGOIRE, Céline; BARON, Frédéric; WILLEMS, Evelyne; BRIQUET, Alexandra; BAUDOUX, Etienne; DELLOYE, Olivier; GIET, Olivier; LECHANTEUR, Chantal; BEGUIN, Yves
    Peer reviewed

  15. Multiple myeloma bone disease: from mechanisms to next generation therapy

    Heusschen, Roy; Muller, Joséphine; WITHOFS, Nadia; BARON, Frédéric; BEGUIN, Yves; CAERS, Jo
    Peer reviewed

  16. A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.

    Zhou, Vivian; Agle, Kimberle; Chen, Xiao; Beres, Amy; Komorowski, Richard; Belle, Ludovic; Taylor, Carolyn; Zhu, Fenlu; Haribhai, Dipica; Williams, Calvin B.; Verbsky, James; Blumenschein, Wendy; Sadekova, Svetlana; Bowman, Eddie; Ballantyne, Christie; Weaver, Casey; Serody, David A.; Vincent, Benjamin; Serody, Jonathan; Cua, Daniel J.; Drobyski, William R.
    Peer reviewed

  17. Blockade of Interleukin 27 Signaling Attenuates Graft Versus Host Disease By Augmenting CD4+ and CD8+ Regulatory T Cell Reconstitution

    Belle, Ludovic; Agle, Kimberlee; Zhou, Vivian; Yin-Yuan, C; Komorowski, Richard; Eastwood; Logan, Brent; Sun, Jay; Ghilardi, Nicolas; Cua, Daniel; Williams, Calvin; Gaignage, Mélanie; Marillier, Reece; van Snick, Jacques; Drobyski, William
    Peer reviewed

  18. Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient: recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

    Boulanger, Florence; Decot, Véronique; Bulliard, Geneviève; Calmels, Boris; Giraud, Christine; Lacassagne, Marie Noelle; Magnani, Alessandra; Pouthier, Fabienne; Thibert, Jean Baptiste; Tirefort, Yorkanda; Yakoub-Agha, Ibrahim; BAUDOUX, Etienne
    Peer reviewed

  19. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides

    Delierneux, Céline; Donis, Nathalie; servais, laurence; Wéra, Odile; LECUT, Christelle; Vandereyken, Maud; Musumeci, Lucia; Rahmouni, Souad; Schneider, jochen; Eble, johannes; LANCELLOTTI, Patrizio; Oury, Cécile
    Peer reviewed

  20. Azacytidine and Decitabine prevent experimental sclerodermic chronic graft-versus-host disease

    Fransolet, Gilles; Ehx, Grégory; SOMJA, Joan; Delens, Loïc; Hannon, Muriel; DUBOIS, Sophie; Drion, Pierre; CAERS, Jo; Humblet-Baron, Stéphanie; Belle, Ludovic; DELVENNE, Philippe; BEGUIN, Yves; Conteduca, Giuseppina; Baron, Frédéric
    Introduction: Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic stem cell transplantation (HSCT). Following allo-transplantation, 60% of the patients experience chronic GVHD while approximately 15% of them develop a sclerodermic form of chronic GVHD characterized by multiple organ fibrosis and loss of skin elasticity. Regulatory T cells (Tregs) play a pivotal protective role in the pathogenesis of chronic GVHD by inhibiting alloreactive conventional T cells (Tconvs). Several studies have shown that hypomethylating agents such as Azacytidine (AZA) or Decitabine (DAC) can demethylate the master transcription factor of Treg (FoxP3), thus promoting Treg differentiation from Tconvs. This work investigates...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.